SPAC

With $100M from its new IPO, XFLH Capital joins a resurgent SPAC market. But can its Asia-focused strategy overcome a history of investor risk?

Top policymakers, including Dr. Agustín Carstens and FATF President Luis Urrutia Corral, will convene in Mérida to address critical cross-border tax issues.

Social Commerce Partners Corp. begins separate trading for its shares and warrants, a key step as it navigates a tough market to find a target in direct selling.

With a new focus on eye disease and fresh funding, Surrozen will present its novel Wnt-based pipeline to investors. What's at stake for the future of sight?

The insurance giant beat adjusted earnings estimates on strong operational performance, even as derivative losses weighed on its reported GAAP revenue.

As X4 Pharmaceuticals preps for a key investor summit, all eyes are on its pivotal trial for chronic neutropenia and the commercial fate of XOLREMDI®.

Pharming Group projects strong 2026 growth, fueling ambitious clinical programs for rare immunodeficiencies and mitochondrial diseases.

Amid a recovering SPAC market, K2 Capital's successful $138M offering launches an ambitious search for targets in robotics, AI, and nuclear energy.